Badri N. Dasu - 03 Mar 2023 Form 4 Insider Report for ACELRX PHARMACEUTICALS INC (TLPH)

Role
Chief Engineering Officer
Signature
/s/ Martha Adler, Attorney-In-Fact
Issuer symbol
TLPH
Transactions as of
03 Mar 2023
Net transactions value
-$521
Form type
4
Filing time
06 Mar 2023, 15:45:22 UTC
Previous filing
14 Feb 2023
Next filing
13 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRX Common Stock Tax liability $521 -398 -2.1% $1.31 18,771 03 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.